(THTX)

Theratechnologies Inc. has completed an acquisition by Future Pak, with shareholders receiving $3.01 per share in cash and a contingent value right (CVR) with potential additional payments of up to $1.19 per share if certain milestones are achieved.

Theratechnologies announced it will report Q2 2025 financial results on July 9, 2025, and will not hold a conference call due to a recent acquisition agreement by CB Biotechnology.

Theratechnologies (THTX) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.